Which numbing drug works best for dialysis access surgery?
NCT ID NCT07259772
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two numbing medicines, ropivacaine and lidocaine, in 40 adults with end-stage kidney disease who need surgery to create a blood vessel connection (fistula) for dialysis. Patients are randomly assigned to receive one of the two drugs during surgery, and neither they nor their surgeons know which one is used. Researchers measure pain levels, surgery time, need for extra pain relief, and how well the fistula works over the next 5 years. The goal is to find which drug provides better pain control and may improve long-term surgical success.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS FISTULA PATENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lianyungang First People's Hospital
Lianyungang, Jiangsu, 222000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple baking soda pill may protect dialysis Patients' blood vessels
- Pill vs. machine: which fixes acid imbalance better for dialysis patients?
- Dialysis filter showdown: could the right membrane tame inflammation?
- Creatine and exercise during dialysis: a new hope for kidney patients?
- Lab-Made blood vessel could free dialysis patients from catheters
- Dentist's deep clean may delay dialysis for kidney patients